S Gastrointestinal - And Liver Disease 12th Edition Hot

Gastrointestinal and Hepatic Manifestations of Coronavirus Infection Enterocolitis and Hepatitis Induced by Cancer Immunotherapy Technological Advances : Expanded coverage of the use of AI in endoscopy for improved detection of GI cancers. Updated Disease Classifications : Includes new discussions on

Sleisenger and Fordtran's Gastrointestinal and Liver Disease - 2 Volume Set - 12th Edition | Elsevier Shop

: Comprehensive parts dedicated to the Esophagus (Part VI), Stomach/Duodenum (Part VII), Pancreas (Part VIII), Biliary Tract (Part IX), and Liver (Part X). Features & Enhanced Learning Tools

The 12th edition explicitly addresses how . It covers deep learning systems used for real-time mucosal analysis, computer-aided detection (CADe) for identifying subtle adenomas during colonoscopies, and computer-aided characterization (CADx) to reduce unnecessary biopsies of benign tissue. 2. Transition from NAFLD to MASLD s gastrointestinal and liver disease 12th edition hot

: Includes expanded discussions on using Artificial Intelligence (AI) in endoscopy for improved cancer detection.

Gastrointestinal and Hepatic Manifestations of Coronavirus Infection Enterocolitis and Hepatitis Induced by Cancer Immunotherapy Technological Integration : New focus on the use of AI in endoscopy for improved cancer detection. Revised Nomenclature : Updated discussion on

The 12th edition is not just a revision; it is a thorough restructuring designed to meet the demands of modern clinical practice. Key hot topics and revisions include: It covers deep learning systems used for real-time

"Finally, a textbook that keeps up with the explosion of new drugs in IBD. The tables comparing efficacy of ustekinumab vs. risankizumab are worth their weight in gold." —

Includes digital video walkthroughs for advanced endoscopic, biliary, and pancreatic procedures.

Sleisenger and Fordtran's Gastrointestinal and Liver Disease Stomach/Duodenum (Part VII)

For medical libraries and practicing physicians deciding whether to upgrade their reference material, the technical improvements are clear:

Includes updated information on biologic agents and novel small molecules for Inflammatory Bowel Disease (IBD) and new treatments for viral hepatitis and autoimmune liver diseases.

Deep-learning algorithms designed to identify early-stage Barrett’s esophagus neoplasia and subtle gastric carcinomas.

: Includes updated discussions on MASLD (Metabolic dysfunction-associated steatotic liver disease), formerly known as non-alcoholic fatty liver disease (NAFLD).

Older public domain materials and indexed metadata associated with the textbook can be referenced through the Internet Archive . 💡 Core Highlights of the 12th Edition: